BACKGROUND: The proliferation of cardiomyocytes is highly restricted after postnatal maturation, limiting heart regeneration. Elucidation of the regulatory machineries for the proliferation and growth arrest of cardiomyocytes is imperative. Chemical biology is efficient to dissect molecular mechanisms of various cellular events and often provides therapeutic potentials. We have been investigating cardiovascular differentiation with pluripotent stem cells. The combination of stem cell and chemical biology can provide novel approaches to investigate the molecular mechanisms and manipulation of cardiomyocyte proliferation. METHODS AND RESULTS: To identify chemicals that regulate cardiomyocyte proliferation, we performed a screening of a defined chemical library based on proliferation of mouse pluripotent stem cell-derived cardiomyocytes and identified 4 chemical compound groups: inhibitors of glycogen synthase kinase-3, p38 mitogen-activated protein kinase, and Ca(2+)/calmodulin-dependent protein kinase II, and activators of extracellular signal-regulated kinase. Several appropriate combinations of chemicals synergistically enhanced proliferation of cardiomyocytes derived from both mouse and human pluripotent stem cells, notably up to a 14-fold increase in mouse cardiomyocytes. We also examined the effects of identified chemicals on cardiomyocytes in various developmental stages and species. Whereas extracellular signal-regulated kinase activators and Ca(2+)/calmodulin-dependent protein kinase II inhibitors showed proliferative effects only on cardiomyocytes in early developmental stages, glycogen synthase kinase-3 and p38 mitogen-activated protein kinase inhibitors substantially and synergistically induced re-entry and progression of cell cycle in neonatal but also as well as adult cardiomyocytes. CONCLUSIONS: Our approach successfully uncovered novel molecular targets and mechanisms controlling cardiomyocyte proliferation in distinct developmental stages and offered pluripotent stem cell-derived cardiomyocytes as a potent tool to explore chemical-based cardiac regenerative strategies.
BACKGROUND: The proliferation of cardiomyocytes is highly restricted after postnatal maturation, limiting heart regeneration. Elucidation of the regulatory machineries for the proliferation and growth arrest of cardiomyocytes is imperative. Chemical biology is efficient to dissect molecular mechanisms of various cellular events and often provides therapeutic potentials. We have been investigating cardiovascular differentiation with pluripotent stem cells. The combination of stem cell and chemical biology can provide novel approaches to investigate the molecular mechanisms and manipulation of cardiomyocyte proliferation. METHODS AND RESULTS: To identify chemicals that regulate cardiomyocyte proliferation, we performed a screening of a defined chemical library based on proliferation of mouse pluripotent stem cell-derived cardiomyocytes and identified 4 chemical compound groups: inhibitors of glycogen synthase kinase-3, p38 mitogen-activated protein kinase, and Ca(2+)/calmodulin-dependent protein kinase II, and activators of extracellular signal-regulated kinase. Several appropriate combinations of chemicals synergistically enhanced proliferation of cardiomyocytes derived from both mouse and human pluripotent stem cells, notably up to a 14-fold increase in mouse cardiomyocytes. We also examined the effects of identified chemicals on cardiomyocytes in various developmental stages and species. Whereas extracellular signal-regulated kinase activators and Ca(2+)/calmodulin-dependent protein kinase II inhibitors showed proliferative effects only on cardiomyocytes in early developmental stages, glycogen synthase kinase-3 and p38 mitogen-activated protein kinase inhibitors substantially and synergistically induced re-entry and progression of cell cycle in neonatal but also as well as adult cardiomyocytes. CONCLUSIONS: Our approach successfully uncovered novel molecular targets and mechanisms controlling cardiomyocyte proliferation in distinct developmental stages and offered pluripotent stem cell-derived cardiomyocytes as a potent tool to explore chemical-based cardiac regenerative strategies.
Authors: Felix B Engel; Michael Schebesta; Mychelle T Duong; Gang Lu; Shuxun Ren; Jeffery B Madwed; Huiping Jiang; Yibin Wang; Mark T Keating Journal: Genes Dev Date: 2005-05-03 Impact factor: 11.361
Authors: L M Strawn; G McMahon; H App; R Schreck; W R Kuchler; M P Longhi; T H Hui; C Tang; A Levitzki; A Gazit; I Chen; G Keri; L Orfi; W Risau; I Flamme; A Ullrich; K P Hirth; L K Shawver Journal: Cancer Res Date: 1996-08-01 Impact factor: 12.701
Authors: Ahmed I Mahmoud; Fatih Kocabas; Shalini A Muralidhar; Wataru Kimura; Ahmed S Koura; Suwannee Thet; Enzo R Porrello; Hesham A Sadek Journal: Nature Date: 2013-04-17 Impact factor: 49.962
Authors: Jan W Buikema; Soah Lee; William R Goodyer; Renee G Maas; Orlando Chirikian; Guang Li; Yi Miao; Sharon L Paige; Daniel Lee; Haodi Wu; David T Paik; Siyeon Rhee; Lei Tian; Francisco X Galdos; Nazan Puluca; Benjamin Beyersdorf; James Hu; Aimee Beck; Sneha Venkamatran; Srilatha Swami; Paul Wijnker; Maike Schuldt; Larissa M Dorsch; Alain van Mil; Kristy Red-Horse; Joy Y Wu; Caroline Geisen; Michael Hesse; Vahid Serpooshan; Stefan Jovinge; Bernd K Fleischmann; Pieter A Doevendans; Jolanda van der Velden; K Christopher Garcia; Joseph C Wu; Joost P G Sluijter; Sean M Wu Journal: Cell Stem Cell Date: 2020-07-02 Impact factor: 24.633
Authors: Laura A Woo; Svyatoslav Tkachenko; Mei Ding; Alleyn T Plowright; Ola Engkvist; Henrik Andersson; Lauren Drowley; Ian Barrett; Mike Firth; Peter Akerblad; Matthew J Wolf; Stefan Bekiranov; David L Brautigan; Qing-Dong Wang; Jeffrey J Saucerman Journal: J Mol Cell Cardiol Date: 2018-12-28 Impact factor: 5.000